This site is intended for healthcare professionals
News

Reyvow showed significant therapeutic gains of 17-21% for pain freedom at 2 hours and met all 18 gated endpoints. Eli Lilly

Read time: 4 mins
Last updated:13th Sep 2020
Published:12th Sep 2020
Condition: Migraine/Headache
Type: drug
Register free for full access to medthority.com